Delivery Order SPE2DE21D7010-SPE2D625F29HP
- Not listed
- This federal contract award, valued at $8,427.00, was issued by the Defense Logistics Agency (DLA) to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a Delivery Order under a Blanket Purchase Agreement (BPA) valued at $8 million that Nuvasive holds with the Defense Health Agency (DHA), an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. The contract provides for the delivery of various spinal medical devices and...
- The U.S. Defense Logistics Agency (DLA) awarded a fixed-price delivery order contract worth $43,183.03 to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract, which has an ultimate completion date of March 29, 2024, was placed against an existing indefinite-delivery/indefinite-quantity (IDIQ) vehicle or blanket purchase agreement (BPA) held by Nuvasive. This BPA, valued at $8 million, was awarded by the Defense Health Agency (DHA) and...
- This federal contract award, valued at $8,427.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The award is a fixed-price delivery order contract with economic price adjustment, with a completion date of May 1, 2024. Nuvasive, Inc. has been awarded multiple prime federal contracts from the Department of Veterans Affairs (VA), DLA, and the Defense Health...
- This federal contract award, valued at $34,971.70, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract is a Fixed Price with Economic Price Adjustment Delivery Order for the reline of open implants, with a completion date of January 6, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract supports the...
- This is a $1,956.60 fixed-price federal contract awarded by the Defense Logistics Agency (DLA) to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order under the Defense Health Agency's (DHA) $8 million Blanket Purchase Agreement (BPA) with Nuvasive for spinal medical devices and instruments. This IDIQ contract vehicle allows various Department of Defense (DoD) and Department of Veterans Affairs (VA) medical facilities...
- This federal contract award, valued at $4,745.79, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, provides a range of advanced spinal implants, instruments, biologics, and related surgical equipment to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract...
- This federal contract award, valued at $46,038.63, was issued by the Defense Logistics Agency (DLA) to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed price and economic price adjustment pricing type, with a period of performance ending on March 17, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract is part of a larger $8 million Blanket...
- This federal contract award, valued at $8,427.00, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed-price and economic price adjustment pricing type, and has an ultimate completion date of May 23, 2025. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, is a key supplier of specialized spinal medical...
- This federal contract award, valued at $1,956.60, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed price and economic price adjustment mechanism, with an ultimate completion date of May 14, 2025. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, has established itself as a key supplier of...
- The U.S. government awarded a $1,956.60 delivery order contract to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract, awarded by the Defense Logistics Agency (DLA) Medical Supply Chain, is a fixed-price contract with economic price adjustment. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, will provide a range of spinal medical devices and surgical instruments, including spinal fusion devices,...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D625F29HPDelivery Order
This federal contract award, valued at $18,454.60, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order under a larger Blanket Purchase Agreement (BPA) valued at $8 million that Nuvasive holds with the Defense Health Agency (DHA). This BPA serves as an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle, allowing DHA and Department of Veterans Affairs (VA) facilities to efficiently access Nuvasive's portfolio of spinal medical devices and instruments, including products like OSTEOCEL PRO. The contract does not have a set-aside designation, indicating Nuvasive's strong competitive position in providing specialized medical technologies to federal healthcare agencies. Nuvasive is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, which also holds significant federal contract awards to supply a comprehensive range of surgical implants, biologics, and instruments to the VA and Department of Defense (DoD).
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 1/15/25 |